AbbVie Inc. (ABBV) vs Humana Inc. (HUM)
ABBV leads on 10 of 15 compared metrics, though HUM is the cheaper stock.
A side-by-side comparison of AbbVie Inc. and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs HUM
growth of $100 · last 14yABBV +544.8%HUM +459.2%ABBV compounded faster
ABBV HUM
ABBV vs HUM: by the numbers
- •ABBV is the larger company ($402.35B vs $45.53B market cap).
- •HUM trades at the lower earnings multiple (40.56 vs 111.67 P/E).
- •ABBV converts more revenue to profit (5.79% vs 0.82% net margin).
- •HUM grew revenue faster over the past five years (11.71% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.96% vs 0.93%).
Which is better, ABBV or HUM?
Metric tally: ABBV 10 · HUM 5It depends on what you're optimizing for:
ValueHUM(lower P/E)
GrowthHUM(faster 5Y revenue CAGR)
IncomeABBV(higher dividend yield)
QualityABBV(higher ROIC)
Valuation
| Metric | ABBV | HUM |
|---|---|---|
| P/E ratio | 111.67 | 40.56● |
| Forward P/E | — | 23.94 |
| P/S ratio | 6.43 | 0.33● |
| P/B ratio | 14.69 | 2.46● |
| EV / EBITDA | 27.63 | 19.22● |
| FCF yield | 5.17%● | 2.78% |
Profitability
| Metric | ABBV | HUM |
|---|---|---|
| Gross margin | 70.68%● | 14.01% |
| Operating margin | 27.60%● | 1.01% |
| Net margin | 5.79%● | 0.82% |
| ROE | 13.23%● | 6.08% |
| ROIC | 12.97%● | 3.12% |
Dividends
| Metric | ABBV | HUM |
|---|---|---|
| Dividend yield | 2.96%● | 0.93% |
| Payout ratio | 284.39% | 35.87% |
Growth (annualized)
| Metric | ABBV | HUM |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 11.71%● |
| EPS CAGR (5Y) | -2.79%● | -17.27% |
| FCF CAGR (5Y) | 3.24%● | -17.19% |
| Total return CAGR (5Y) | 18.95%● | -1.01% |
Frequently asked
- Which is better, ABBV or HUM?
- It depends on your goal. value: HUM (lower P/E); growth: HUM (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: ABBV (higher ROIC). Across all compared metrics, ABBV leads 10 to 5.
- Is ABBV or HUM cheaper?
- On trailing earnings, HUM is cheaper: ABBV trades at a 111.67 P/E and HUM at 40.56.
- Which has grown faster, ABBV or HUM?
- Over the past five years, HUM grew revenue faster — ABBV at a 4.59% CAGR versus HUM at 11.71%.
- Does ABBV or HUM pay a bigger dividend?
- ABBV yields 2.96% and HUM yields 0.93% based on trailing dividends and the latest price.
- Is ABBV or HUM more profitable?
- ABBV runs the higher net margin — ABBV at 5.79% versus HUM at 0.82%.
- Which has been the better investment, ABBV or HUM?
- Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus HUM at 8.24%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioHumana P/E ratioAbbVie dividend yieldHumana dividend yieldAbbVie ROEHumana ROEAbbVie operating marginHumana operating marginAbbVie revenue growthHumana revenue growthAbbVie free cash flowHumana free cash flow
AbbVie & Humana appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.